Flebogrif a mechanical-chemical obliteration system developed by a Polish company Balton, is one of the newest methods of treating varicose veins, being a combination of endovascular treatment with a catheter and foam, it is an improvement of echosclerotherapy- combines an
element of a mechanical damage to the vascular endothelium with a chemical reaction caused by the obliterator agent put into the vessel in the foam.
The two combined mechanisms leading to vein fibrosis are more effective-particularly in inefficient veins over 6mm in diameter-than foam echosclerotherapy.
In such cases, treatment with radio thermal ablation or laser ablation is often recommended, which in turn is much more expensive.
Catheters are used for the treatment as in radio thermal ablation or laser ablation but local anesthesia is not needed.
The catheter is inserted into the vein under ultrasound control through which an obliterating agent is given. The entire treatment takes about 30 minutes, and after it the patient can leave the clinic immediately.
Treatment with the Flebogrif system is a new method. So far it is used by a few centers in Poland. According to studies conducted so far, after 12 months of observation, the effect was maintained 90%, the percentage of complications was low and similar to other methods of mechanical-chemical obliteration.
An additional advantage is undoubtedly the price of the treatment, lower in comparison to other methods of endovascular treatment of veins.
The advantages of the Flebogrif treatment:
- Greater effectiveness compared to echosclerotherapy.
- Short treatment time of about 30 minutes.
- Ambulatory mode of treatment.
- Lower cost compared to EVRF.
- No need for tumescent anesthesia.